NINJA
12 Apr 2022
Trial Summary
NINJA: Phase II Novel integration of New prostate radiation therapy schedules with adjuvant Androgen deprivation
Acronym:
NINJA
ACTRN/NCT /ethics:
ACTRN12618001806257
Scientific title:
Novel Integration of new prostate radiation therapy schedules with adjuvant androgen deprivation
Sponsor / Cooperative group:
Trans Tasman Radiation Oncology Group
Trial & Patient Characteristics
| Cancer Type | Prostate |
|---|---|
| Trial Type | Treatment |
| Phase | Phase II |
| Age Range | 18 years and older |
| Sex | Male |
| Tumour Stream | - |
| Cancer Stage | Early\In Situ |
| Anticipated Start Date | 2018-11-02 |
| Anticipated End Date | 2026-12-31 |
Participating Hospitals
| Hospital | Royal Adelaide Hospital |
|---|---|
| Clinical Trial Coordinator | Anne Milton |
| anne.milton@sa.gov.au | |
| Phone | 08 7074 2342 |
| Principal Investigator | Dr Peter Gorayski |
| Recruitment Status | Recruiting |
| Hospital | GenesisCare |
|---|---|
| Clinical Trial Coordinator | Kimberley Ruxton |
| Kimberley.Ruxton@genesiscare.com | |
| Phone | - |
| Principal Investigator | Dr Marcus Dreosti |
| Recruitment Status | Recruiting |